[1] Wang F, Zhang J, Zhou G. The mTOR-glycolytic pathway promotes T-cell immunobiology in oral lichen planus[J]. Immunobiology, 2020: 151933. doi: 10.1016/j.imbio.2020.151933. [2] 周刚,刘宏伟,林梅,等. 口腔扁平苔藓(萎缩型、糜烂型)疗效评价标准(试行)[J]. 中华口腔医学杂志, 2005, 2: 8-9. [3] Bokor-Bratic M, Cankovic M, Dragnic N. Unstimulated whole salivary flow rate and anxiolytics intake are independently associated with oral Candida infection in patients with oral lichen planus[J]. Eur J Oral Sci, 2013, 121: 427-433. [4] He H,Xia XY, Yang HP,et al. A pilot study: A possible implication of Candida as an etiologically endogenous pathogen for oral lichen planus[J]. BMC Oral Health, 2020, 20: 72.doi: 10.1186/s12903-020-1042-8. [5] Firth FA, Friedlander LT, Parachuru VP, et al. Regulation of immune cells in oral lichen planus[J]. Arch Dermatol Res, 2015, 307: 333-339. [6] Drućijanić A, Glavina A, Draganja M, et al. Inflammatory markers and incidence of other autoimmune diseases in patients with oral lichen planus[J]. Acta Stomatol Croat, 2019, 53: 363-370. [7] van de Veerdonk FL, Stoeck man AK, Wu G, et al. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist[J]. Proc Natl Acad Sci U S A, 2012, 109: 3001-3005. [8] Odak I, Depkat-Jakob A, Beck M, et al. Donor-derived IL-17A and IL-17F deficiency triggers Th1 allo-responses and increases gut leakage during acute GVHD[J]. PLoS One, 2020, 15: e0231222.doi: 10.1371/journal.pone.0231222. [9] Ge XJ, Xie HT, Nguyen T, et al. Renin promotes STAT4 phosphorylation to induce IL-17 production in keratino-cytes of oral lichen planus[J]. Science, 2020, 23: 100983. doi: 10.1016/j.isci.2020.100983. [10] Gueiros LA, Arão T,Souza T, et al. IL17A polymorphism and elevated IL17A serum levels are associated with oral lichen planus[J].Oral Dis, 2018, 24: 377-383. [11] Zarrabi M, Gholijani N, Shenavandeh S, et al. IL-38 serum levels in patients with Behcet's disease and the relationship with clinical features[J]. Eur Cytokine Netw, 2019, 30: 82-87. [12] Ma DM, Li QY, Jin DH, et al. A case of lupus miliaris disseminatus faciei that was successfully treated with 595 nm pulsed-dye laser combined with drugs[J]. Dermatol Ther, 2020: e13373. doi: 10.1111/dth.13373. [13] Cosgarea R, Pollmann R, Sharif J, et al. Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study[J]. Sci Rep, 2020, 10: 1667.doi: 10.1038/s41598-020-58548-9. [14] Lavaee F, Shadmanpour M. Comparison of the effect of photodynamic therapy and topical corticosteroid on oral lichen planus lesions[J]. Oral Dis, 2019, 25: 1954-1963. [15] Seyedmousavi S, Hashemi SJ, Rezaie S, et al. Effects of low-level laser irradiation on the pathogenicity of Candida albicans: in vitro and in vivo study[J]. Photomed Laser Surg, 2014, 32: 322-329. [16] Khater Mohamed M, Khattab Fathia M. Efficacy of 1064 Q switched Nd:YAG laser in the treatment of oral lichen planus[J]. J Dermatolog Treat, 2019: 1-5.doi: 10.1080/09546634.2019.1638881. [17] Mirza S, Rehman N, Alrahlah A, et al. Efficacy of photodynamic therapy or low level laser therapy against steroid therapy in the treatment of erosive-atrophic oral lichen planus[J]. Photodiagnosis Photodyn Ther, 2018, 21: 404-408. |